Table 2. Summary of echocardiographic findings of interest.
Echocardiogram finding | SB cases | BB cases | SB prevalence (95% CI) | BB prevalence (95% CI) | Relative risk | p-value |
---|---|---|---|---|---|---|
Aorta dilation | 1 / 20 | 0 / 34 | 0.05 (0–0.25) | 0 (0–0.12) | 0 | 0.370 |
Aortic valve thickening | 0 / 18 | 10 / 29 | 0 (0–0.21) | 0.34 (0.2–0.53) | NA | 0.008 |
Mitral valve prolapse | 3 / 18 | 10 / 29 | 0.17 (0.05–0.4) | 0.34 (0.2–0.53) | 2.07 | 0.315 |
Mitral valve regurgitation | 5 / 20 | 6 / 34 | 0.25 (0.11–0.47) | 0.18 (0.08–0.34) | 0.71 | 0.728 |
Pulmonary artery dilation | 0 / 16 | 1 / 23 | 0 (0–0.23) | 0.04 (0–0.23) | NA | 1.000 |
Tricuspid valve prolapse | 0 / 15 | 11 / 27 | 0 (0–0.24) | 0.41 (0.24–0.59) | NA | 0.003 |
Tricuspid valve regurgitation | 3 / 20 | 6 / 34 | 0.15 (0.04–0.37) | 0.18 (0.08–0.34) | 1.18 | 1.000 |
Tricuspid valve thickening | 1 / 16 | 10 / 27 | 0.06 (0–0.3) | 0.37 (0.21–0.56) | 5.93 | 0.033 |
Prevalence was compared between SB and BB, and p-values ≤ 0.05 are reported in bold.